Related references
Note: Only part of the references are listed.Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers
Susmita Mondal et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
The JNK signaling pathway plays a key role in methuosis (non-apoptotic cell death) induced by MOMIPP in glioblastoma
Zehui Li et al.
BMC CANCER (2019)
Protein N-glycosylation alteration and glycolysis inhibition both contribute to the antiproliferative action of 2-deoxyglucose in breast cancer cells
Audrey Berthe et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Mahanine drives pancreatic adenocarcinoma cells into endoplasmic reticular stress-mediated apoptosis through modulating sialylation process and Ca2+-signaling
Sayantani Sarkar Bhattacharya et al.
SCIENTIFIC REPORTS (2018)
Cisplatin and Pemetrexed Activate AXL and AXL Inhibitor BGB324 Enhances Mesothelioma Cell Death from Chemotherapy
Derek B. Oien et al.
FRONTIERS IN PHARMACOLOGY (2018)
Blockage of glycolysis by targeting PFKFB3 suppresses tumor growth and metastasis in head and neck squamous cell carcinoma
Hui-Min Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Determination of glucose deficiency-induced cell death by mitochondrial ATP generation-driven proton homeostasis
Yanfen Cui et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2017)
Macropinocytosis: A Metabolic Adaptation to nutrient Stress in Cancer
Maria Victoria Recouvreux et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
Roles of PFKFB3 in cancer
Linlin Shi et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2017)
The UPR reduces glucose metabolism via IRE1 signaling
Judith M. van der Harg et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2017)
Metabolic scavenging by cancer cells: when the going gets tough, the tough keep eating
Evdokia Michalopoulou et al.
BRITISH JOURNAL OF CANCER (2016)
The Emerging Hallmarks of Cancer Metabolism
Natalya N. Pavlova et al.
CELL METABOLISM (2016)
PFKFB3 modulates glycolytic metabolism and alleviates endoplasmic reticulum stress in human osteoarthritis cartilage
Jining Qu et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2016)
Uses and abuses of macropinocytosis
Gareth Bloomfield et al.
JOURNAL OF CELL SCIENCE (2016)
Synthesis and Biological Evaluation of Indolyl-Pyridinyl-Propenones Having Either Methuosis or Microtubule Disruption Activity
Christopher J. Trabbic et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancer
Susmita Mondal et al.
ONCOTARGET (2015)
Mahanine synergistically enhances cytotoxicity of 5-fluorouracil through ROS-mediated activation of PTEN and p53/p73 in colon carcinoma
Ranjita Das et al.
APOPTOSIS (2014)
Coupling G2/M arrest to the Wnt/β-catenin pathway restrains pancreatic adenocarcinoma
Sayantani Sarkar et al.
ENDOCRINE-RELATED CANCER (2014)
6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27
A. Yalcin et al.
CELL DEATH & DISEASE (2014)
PFKFB3 activation in cancer cells by the p38/MK2 pathway in response to stress stimuli
Laura Novellasdemunt et al.
BIOCHEMICAL JOURNAL (2013)
Role of PFKFB3-Driven Glycolysis in Vessel Sprouting
Katrien De Bock et al.
CELL (2013)
Oxidative inhibition of Hsp90 disrupts the super-chaperone complex and attenuates pancreatic adenocarcinoma in vitro and in vivo
Sayantani Sarkar et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Phosphofructokinase deficiency impairs ATP generation, autophagy, and redox balance in rheumatoid arthritis T cells
Zhen Yang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Targeting 6-Phosphofructo-2-Kinase ( PFKFB3) as a Therapeutic Strategy against Cancer
Brian F. Clem et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Activation of the Unfolded Protein Response by 2-Deoxy-D-Glucose Inhibits Kaposi's Sarcoma-Associated Herpesvirus Replication and Gene Expression
Howard J. Leung et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Targeting glucose metabolism for cancer therapy
Robert B. Hamanaka et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
The JAK2V617F oncogene requires expression of inducible phosphofructokinase/fructose-bisphosphatase 3 for cell growth and increased metabolic activity
M. M. Reddy et al.
LEUKEMIA (2012)
ER stress modulates cellular metabolism
Xiaoli Wang et al.
BIOCHEMICAL JOURNAL (2011)
Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008
Vanya Delgermaa et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Malignant Pleural Mesothelioma
Anne S. Tsao et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB3) is up-regulated in high-grade astrocytomas
Renate Kessler et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Signal integration in the endoplasmic reticulum unfolded protein response
David Ron et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Why do cancers have high aerobic glycolysis?
RA Gatenby et al.
NATURE REVIEWS CANCER (2004)
The stimulation of glycolysis by hypoxia in activated monocytes is mediated by AMP-activated protein kinase and inducible 6-phosphofructo-2-kinase
AS Marsin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
